The tanks’ quick movements, rotating turrets and flexibility to respond to threats inspired Dr. Moses to search for a similar solution and find a way for antibiotics to respond flexibly to their environments. That’s when he discovered bullvalene, a molecule that contains atoms that can swap their positions and change configurations. It led him to combine bullvalene with antibiotics and see if it improved the medicine’s bacteria-fighting capabilities.
“He turned to click chemistry, a Nobel Prize-winning class of fast, high-yielding chemical reactions that ‘click’ molecules together reliably,” according to an April 4 news release. “This makes the reactions more efficient for wide-scale use.”
Dr. Moses worked with Tatiana Soares da-Costa, PhD, a researcher from the University of Adelaide in Australia, to test the new combination. They found that “the shape-shifting antibiotic significantly more effective than vancomycin at clearing the deadly infection. Additionally, the bacteria didn’t develop resistance to the new antibiotic.”
Their findings could be used to create several new, stronger drugs, according to the news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.